Gregory Scott Duncan - Dec 12, 2022 Form 4/A - Amendment Insider Report for Virios Therapeutics, Inc. (VIRI)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Greg Duncan
Stock symbol
VIRI
Transactions as of
Dec 12, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
2/15/2023, 11:54 AM
Date Of Original Report
Dec 14, 2022
Previous filing
Jun 30, 2022
Next filing
Jan 18, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIRI Stock Option (right to buy) Award $0 +410K $0.00 410K Dec 12, 2022 Common Stock 410K $0.28 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person filed a Form 4 on December 14, 2022 which incorrectly reported that on December 12, 2022 he was granted 480,000 Stock Options. This Form 4 amendment is being filed for the purpose of amending and restating the Form 4 to reflect that the reporting person was granted 410,000 Stock Options.
F2 The stock option vests one-third on December 12, 2023 and 1/24th monthly thereafter.